Bengaluru-based SwishX, which describes itself as the world's first agentic AI platform built specifically for pharmaceutical and medtech companies, has been selected for the Anthropic and AWS Agentic AI Accelerator 2026, an India-focused initiative supporting startups developing next-generation autonomous AI applications.

The accelerator programme, which officially begins on June 26 in Bengaluru, has selected 40 early-stage startups building agentic AI systems capable of autonomously executing complex workflows rather than simply generating responses. 

Participants will receive technical mentorship, engineering and product guidance, access to Anthropic's frontier AI models, AWS cloud infrastructure and credits, as well as opportunities to collaborate with AI researchers, enterprise customers, and technology experts from Anthropic and Amazon Web Services (AWS).

SwishX was recognised for its focus on developing agentic AI solutions tailored to the pharmaceutical industry, where commercial operations often continue to rely on fragmented systems, manual workflows, spreadsheets, and delayed reporting mechanisms.

The company has developed AI agents designed to autonomously execute commercial processes and support data-driven decision-making. Its platform helps pharmaceutical companies identify public tenders with the highest probability of success, detect revenue leakages across distribution channels, analyse retailer sales performance, evaluate physician engagement programmes, and optimise field-force execution.

Dushyant Sapre, Co-founder and CEO of SwishX, said, "We started SwishX with the belief that life sciences is one of the biggest untapped opportunities for agentic AI. While many industries embraced digital transformation, pharma commercial operations remained heavily dependent on fragmented workflows and manual processes. Our mission is to build AI agents that go beyond assisting users to autonomously execute complex commercial tasks."